Literature DB >> 13123539

Histogenesis and clinicopathologic correlation of nevi and malignant melanomas; current status.

A C ALLEN, S SPITZ.   

Abstract

Entities:  

Keywords:  MELANOMA/pathology; NEVUS

Mesh:

Year:  1954        PMID: 13123539     DOI: 10.1001/archderm.1954.01540140018002

Source DB:  PubMed          Journal:  AMA Arch Derm Syphilol        ISSN: 0096-5979


× No keyword cloud information.
  16 in total

1.  [CONTRIBUTION TO THE STUDY OF MELANOTIC TUMORS OF THE UVEA AND THEIR ORIGIN].

Authors: 
Journal:  Doc Ophthalmol       Date:  1963       Impact factor: 2.379

2.  [COMPARATIVE STUDIES ON THE MALIGNANCY OF MELANOCYTOBLASTOMA OF THE EYE AND SKIN].

Authors:  W JAENISCH; B SCHULZE
Journal:  Arch Klin Exp Dermatol       Date:  1963-08-07

3.  [CONTRIBUTION TO THE CLINICAL PICTURE AND HISTOLOGY OF NEVOCELLULAR NEVI AND JUVENILE MELANOMA. II. THE UNIQUE POSITION OF JUVENILE MELANOMA].

Authors:  R SCHUHMACHERS-BRENDLER
Journal:  Arch Klin Exp Dermatol       Date:  1963-12-10

4.  [BLUE NEURONEVUS OF MASSON--CELLULAR BLUE NEVUS ALLEN].

Authors:  H GARTMANN
Journal:  Arch Klin Exp Dermatol       Date:  1965

5.  [Recent morphological aspects of malignant melanoma].

Authors:  J J HERZBERG
Journal:  Arch Klin Exp Dermatol       Date:  1962-11-12

6.  [Blue nervus with solitary metastases in the lung and adrenal gland].

Authors:  J J HERZBERG; U E KLEIN
Journal:  Arch Klin Exp Dermatol       Date:  1960

7.  [Nevi and melanomas. II. Contribution to the pathology of melanomas].

Authors:  H T SCHREUS
Journal:  Z Krebsforsch       Date:  1961

8.  Some etiological factors in the production of malignant melanoma.

Authors:  F N GHADIALLY
Journal:  Experientia       Date:  1960-07-15

9.  [Diagnosis and therapy of melanocytoblastoma].

Authors:  J J HERZBERG
Journal:  Arch Klin Exp Dermatol       Date:  1956

Review 10.  [Primary malignant melanoma of the uterine cervix. Report of two cases and review of the literature].

Authors:  C Boldt; R Lehmann; R Osmers; K F Bürrig
Journal:  Pathologe       Date:  2003-02-12       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.